SLV-334

DB15356InvestigationalSmall molecule

SLV-334 is under investigation in clinical trial NCT00735085 (A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.).

Chemical structure of SLV-334
Formula / weight
C33H36N2O6 · 556.659 g/mol (avg)
Code names
SLV-334

Resolves to

Compound
UNII3613ZP748KCAS182821-33-6
Structure
InChIKeyLOFDNSDPZTVIIO-VPUSJEBWSA-NSMILESOC(=O)CN1C2=CC=CC=C2CC[C@H](NC(=O)C2(C[C@@H](CCC3=CC=CC4=CC=CC=C34)C(O)=O)CCCC2)C1=O
Targets
P08473MME

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with SLV-334, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In